You May Also Like
AllFeatures
FimmCyte obtains CHF 1 million from the UZH Life Sciences Fund
FimmCyte obtains CHF 1 million from the UZH Life Sciences Fund
lenka29.02.2024
AllFeatures
Synendos Therapeutics granted EMA clinical trial authorisation
Synendos Therapeutics granted EMA clinical trial authorisation
lenka18.01.2024
AllFeatures
William Pao joins Alentis Therapeutics as independent board member
William Pao joins Alentis Therapeutics as independent board member
lenka09.01.2024